H.R. 1492, Ensuring Pathways to Innovative Cures (EPIC) Act Prescription Drug Pricing Policy
Literal federal measure citations: H.R. 1492
2025 · 4th Quarter (Oct 1 - Dec 31)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Filed by YC CONSULTING, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- YC CONSULTING, LLC
- Filing UUID
- 9ccd08c1-e9de-4788-9e36-f18223c1c53c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Biopharmaceutical patent and intellectual property policy issues
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.